Use of GLP-1 or analogs to abolish catabolic changes after surgery

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6006753
SERIAL NO

08916991

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention provides a method of attenuating post-surgical catabolic changes and hormonal responses to stress. GLP-1, a GLP-1 analog, or a GLP-1 derivative, is administered at a dose effective to normalize blood glucose.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ELI LILLY AND COMPANYLILLY CORPORATE CENTER PATENT DIVISION INDIANAPOLIS IN 46285

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Efendic, Suad Lidingo, SE 23 1366

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation